Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Skinvisible Pharmaceuticals Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011799
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Skinvisible Pharmaceuticals Inc (Skinvisible Pharmaceuticals), a subsidiary of Skinvisible Inc is a pharmaceutical company that develops and manufactures prescription and over the counter dermatology, medical, cosmetic, consumer goods, and skincare products. The company’s products include anti-aging products, pre-surgical preparations, acne moisturizer, anti-itch spray, foot cream and spray, sunburn relief, antimicrobial hand sanitizing lotions, anti- inflammatory products, topical analgesics and first aid, among others. It uses invisicare technology for topical and mucosal products that binds ingredients to the skin and enhances their delivery. Skinvisible Pharmaceuticals conducts in-house research, development and testing of its invisicare polymer delivery vehicles. It serves pharmaceutical, skincare, cosmetic and consumer goods companies. Skinvisible Pharmaceuticals is headquartered in Las Vegas, Nevada, the US.

Skinvisible Pharmaceuticals Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Merger 10
Skinvisible Pharma Plans to Merge with Quoin Pharma 10
Licensing Agreements 11
Canopy Growth Enters into License Agreement with Skinvisible Pharma 11
CannaSkin Enters into Licensing Agreement with Skinvisible Pharma 12
Skinvisible Pharmaceuticals Inc – Key Competitors 13
Skinvisible Pharmaceuticals Inc – Key Employees 14
Skinvisible Pharmaceuticals Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Product News 16
Jul 07, 2017: Skinvisible Improves the Delivery of Cannabis with Patented Invisicare Technology 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Skinvisible Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Skinvisible Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Skinvisible Pharma Plans to Merge with Quoin Pharma 10
Canopy Growth Enters into License Agreement with Skinvisible Pharma 11
CannaSkin Enters into Licensing Agreement with Skinvisible Pharma 12
Skinvisible Pharmaceuticals Inc, Key Competitors 13
Skinvisible Pharmaceuticals Inc, Key Employees 14

★海外企業調査レポート[Skinvisible Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Caladrius Biosciences Inc (CLBS)-医療機器分野:企業M&A・提携分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc is a clinical stage development company that develops and manufactures cell therapy products. The company’s products are based on its proprietary technologies such as Dendritic Cell-Tumor Cell technology; CD34 technology; and T Regu …
  • Harman International Industries Inc:企業の戦略的SWOT分析
    Harman International Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Accuray Inc (ARAY):製品パイプライン分析
    Summary Accuray Inc (Accuray) carries out the development, manufacture and sale of personalized treatment solutions for radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image guided radiation therapy, and adaptive radiation therapy. The company’s major produc …
  • PT Rekayasa Industri:企業の戦略的SWOT分析
    PT Rekayasa Industri - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Empresa De Telecomunicaciones De Bogota S.A. E.S.P. (ETB):企業の財務・戦略的SWOT分析
    Empresa De Telecomunicaciones De Bogota S.A. E.S.P. (ETB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the compan …
  • KDDI Corporation:企業の戦略・SWOT・財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Enerjisa Enerji AS (ENJSA):企業の財務・戦略的SWOT分析
    Enerjisa Enerji AS (ENJSA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • A.P. Eagers Ltd:企業の戦略・SWOT・財務分析
    A.P. Eagers Ltd - Strategy, SWOT and Corporate Finance Report Summary A.P. Eagers Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Rumex International Co:製品パイプライン分析
    Summary Rumex International Co (Rumex International) is a medical device company that manufactures and markets precision instruments for ophthalmology and cardiovascular surgery. The company provides products, which include blade holders, forceps, glaucoma instruments, hooks, lasik and lasek instrum …
  • GEA Group Aktiengesellschaft:企業の戦略・SWOT・財務分析
    GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report Summary GEA Group Aktiengesellschaft - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • ICICI Prudential Life Insurance Company Limited:企業の戦略・SWOT・財務情報
    ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report Summary ICICI Prudential Life Insurance Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • NGM Biopharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary NGM Biopharmaceuticals Inc (NGM Bio) is a clinical-stage biopharmaceutical company that develops pipeline of biological therapeutics for the treatment of cardio-metabolic, immuno-oncology, retinal and liver diseases. The company’s pipeline products include NGM282, NGM386, NGM395, NGM621, NGM …
  • Cosmo Energy Holdings Co Ltd (5021):企業の財務・戦略的SWOT分析
    Cosmo Energy Holdings Co Ltd (5021) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Hays plc:企業の戦略・SWOT・財務分析
    Hays plc - Strategy, SWOT and Corporate Finance Report Summary Hays plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • MIE Holdings Corp (1555):石油・ガス:M&Aディール及び事業提携情報
    Summary MIE Holdings Corp (MIEH), a subsidiary of Far East Energy Ltd is an oil and gas company that carries out exploration, development and production activities. The company operates Daan, Moliqing and Miao 3 oilfields in the Songliao Basin. Its Daan oilfield is located in Daan City that covers a …
  • Emco Ltd (EMCO):電力:M&Aディール及び事業提携情報
    Summary Emco Ltd (Emco) is a power company that manufactures and markets electrical products and solutions. The company's products include transformers, substations, energy metering systems, and transmission towers and lines. Its transformers comprise furnace transformers, distribution transformers, …
  • German Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and pr …
  • China National Chemical Corp:企業の戦略的SWOT分析
    China National Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Antisense Therapeutics Ltd (ANP):企業の財務・戦略的SWOT分析
    Antisense Therapeutics Ltd (ANP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Clinigen Group Plc (CLIN):製薬・医療:M&Aディール及び事業提携情報
    Summary Clinigen Group Plc (Clinigen Group) is a pharmaceutical and services company that provides access to clinical trials, medicines, unlicensed and commercial supply. The company acquires and licenses essential commercial medicines such as foscavir, cardioxane, ethyol, savene and vibativ. It off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆